Results of new Alzheimer’s drug ‘historic’, but concerns about side effects | Science

Doctors have called the results of a trial of the new Alzheimer’s drug Lecanemab “historic and hopeful”. They don’t think it’s a panacea, but they see the fact that a drug has succeeded in slowing down the brain’s decline as a major breakthrough. However, there are concerns about possible side effects.